Product NDC: | 59726-127 |
Proprietary Name: | Acid Reducer |
Non Proprietary Name: | Ranitidine |
Active Ingredient(s): | 150 mg/1 & nbsp; Ranitidine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59726-127 |
Labeler Name: | P and L Development of New York Corporation |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA078653 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130325 |
Package NDC: | 59726-127-10 |
Package Description: | 1 BOTTLE in 1 BOX (59726-127-10) > 150 TABLET in 1 BOTTLE |
NDC Code | 59726-127-10 |
Proprietary Name | Acid Reducer |
Package Description | 1 BOTTLE in 1 BOX (59726-127-10) > 150 TABLET in 1 BOTTLE |
Product NDC | 59726-127 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ranitidine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130325 |
Marketing Category Name | ANDA |
Labeler Name | P and L Development of New York Corporation |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes |